Dafna Capital Management LLC Spruce Biosciences, Inc. Transaction History

Dafna Capital Management LLC

  • $389 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$1.04 - $2.93 $22,484 - $63,346
-21,620 Reduced 3.79%
548,510 $1.61 Million
Q3 2023

Nov 14, 2023
BUY
$2.04 - $2.54 $526,585 - $655,650
258,130 Added 82.73%
570,130 $1.29 Million
Q1 2023

May 15, 2023
BUY
$1.15 - $3.17 $358,800 - $989,040
312,000 New
312,000 $689,000

Others Institutions Holding SPRB

# of Institutions
34
Shares Held
15.4M
Call Options Held
16.7K
Put Options Held
1.1K
View Full List

About SPRUCE BIOSCIENCES, INC.

SPRB Quotes by TradingView
  • Ticker SPRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,560,200
  • Market Cap $8.95M
  • Description
  • Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...
More about SPRB
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email